Diagnosis of arrhythmo- genic right ventricular cardiomyopathy/dysplasia: proposed modifi- cation of the task force criteria. Circulation. 2010;121:1533 41. S7.3-7. te Riele AS, Bhonsale A, James CA, et al. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratifica- tion of arrhythmogenic right ventricular dysplasia/cardiomyopa- thy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013;62:1761 9. S7.3-8. Vermes E, Strohm O, Otmani A, et al. Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. JACC Cardiovasc Imag. 2011;4:282 7. S7.3-9. Bhonsale A, James CA, Tichnell C, et al. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy under- going implantable cardioverter-defibrillator implantation for pri- mary prevention. J Am Coll Cardiol. 2011;58:1485 96. CLINICAL STATEMENTS AND GUIDELINES S7.3-10. Corrado D, Calkins H, Link MS, et al. Prophylactic implantable defi- brillator in patients with arrhythmogenic right ventricular cardiomy- opathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation. 2010;122:1144 52. S7.3-11. Corrado D, Wichter T, Link MS, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Circulation. 2015;132:441 53. S7.3-12. Link MS, Laidlaw D, Polonsky B, et al. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, charac- teristics, and treatment. J Am Coll Cardiol. 2014;64:119 25. S7.3-13. Piccini JP, Dalal D, Roguin A, et al. Predictors of appropriate implant- able defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm. 2005;2:1188 94. S7.3-14. Marcus FI, Zareba W, Calkins H, et al. Arrhythmogenic right ventric- ular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm. 2009;6:984 92. S7.3-15. Marcus GM, Glidden DV, Polonsky B, et al. Efficacy of antiarrhyth- mic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. 